Pediatrics News

The FDA cleared Luminopia, a virtual reality-based therapeutic for amblyopia, for use in children aged 8 to 12 years old, adding to its existing approval in children aged 4 to 7 years old, according to a press release.

Regardless of duration of treatment, children who stopped wearing dual-focus contact lenses for myopia control maintained prior treatment gains, with eye growth rates similar to those of untreated myopic eyes, according to a study.

Dual-focus contact lenses appeared effective in high myopia in teenagers and young adults, according to a study published in Ophthalmic and Physiological Optics.

SEVILLE, Spain — Whether atropine should be the standard of care for halting myopia progression was a hot topic discussed at the Congress on Controversies in Ophthalmology.

Flash photos typically produce a red reflection in people’s eyes, but sometimes that reflection can appear white or gray, which is known as leukocoria.

Among children, errors of refraction and strabismic amblyopia were the most common causes of low vision, with retinal diseases most often causing severe vision loss, according to a study.

Myopes may undergo about –1 D of progression between the ages of 20 and 50 years, according to an analysis of three large studies published in Investigative Ophthalmology & Visual Science.

The FDA accepted a new drug application for SYD-101 to slow the progression of pediatric myopia and assigned a Prescription Drug User Fee Act date of Oct. 23, according to a press release from Sydnexis.

Scleral lenses demonstrated safety and efficacy for treating ocular surface disease and irregular cornea/refractive conditions in children, according to an approximately 2-decade long study published in Clinical Optometry.